Cell Cycle and Cervical Carcinoma 101. Busby-Earle RM, Steel CM, Williams AR, Cohen B, Bird CC. p53 mutations in cervical carcinogenesis low frequency and lack of correlation with human papillomavirus status. Br J Cancer 1994;69:732-7. 102. Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M, Loning T. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer 1995;63:639-45. 103. Horner SM, DeFilippis RA, Manuelidis L, DiMaio D. Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senes- cence and apoptosis in HeLa cervical carcinoma cells. J Virol 2004;78:4063-73. 104. Helland A, Holm R, Kristensen G, Kaern J, Karlsen F, Trope C, et al. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. J Pathol 1993;171:105-14. 105. Benjamin I, Saigo P, Finstad C, Takahashi H, Federici M, Rubin SC, et al. Expression and mutational an- alysis of p53 in stage IB and IIA cervical cancers. Am J Obstet Gynecol 1996;175:1266-71. 106. Avall-Lundqvist EH, Silfversward C, Aspenblad U, Nilsson BR, Auer GU. The impact of tumour angio- genesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma. Eur J Cancer 1997;33:1799-804. 107. Cho NH, Lim SY, Kim YT, Kim D, Kim YS, Kim JW. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value. Gynecol Oncol 2003;90:15-22. 108. Nurse P. Ordering of S phase and M phase in the cell cycle. Cell 1994:79:547-50. 109. Zehbe I, Ratsch A, Alunni-Fabbroni M, Burzlaff A, Bakos E, Durst M, et al. Overriding of cyclin-depen- dent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions. Oncogene 1999;18:2201-11. 110. Theron T, Bohm L. Influence of the G2 cell cycle block abrogator pentoxifylline on the expression and subcel- lular location of cyclin B1 and p34cdc2 in HeLa cervi- cal carcinoma cells. Cell Prolif 2000;33:39-50. 111. Hashiguchi Y, Tsuda H, Nishimura S, Inoue T, Kawamura N, Yamamoto K. Relationship between HPV typing and the status of G2 cell cycle regulators in cervical neoplasia. Oncol Rep 2004;12:587-91. Yonsei Med J Vol. 46, No. 5, 2005